Long-term Exposure to Lifelong Therapies
- 1 February 2002
- journal article
- review article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 29, S28-S40
Abstract
Three categories of highly active antiretroviral therapy (HAART)associated major toxic effects have been identified: nucleoside-related toxic effects (e.g., neuropathy, myopathy, pancreatitis, hepatic steatosis, lactic acidosis, and possibly lipoatrophy), metabolic complications (e.g., fat redistribution, insulin resistance, and hyperlipidemia), and bone disease (e.g., osteopenia and/or osteoporosis). The toxic effects caused by nucleosides are hypothesized to be a result of mitochondrial injury and include myopathy, pancreatitis, liver failure, and lactic acidosis. Alterations in lactic acid metabolism range from common instances of asymptomatic lactic acidemia to rare occurrences of life-threatening lactic acidosis with hepatic steatosis. A metabolic syndrome consisting of lipodystrophy (i.e., fat redistribution), hyperlipidemia and insulin resistance has been observed, particularly with protease inhibitor treatment. Some additive interaction between protease inhibitors and nucleosides has also been described. The potential relationship of these metabolic abnormalities to increased risk of cardiovascular disease and diabetes has broad implications on long-term patient management. Lipodystrophy associated with HAART is generally accompanied by potentially serious abnormalities, including dyslipidemia (i.e., hypercholesterolemia and hypertriglyceridemia) and altered glucose metabolism (i.e., insulin resistance). Regimens of HAART may have adverse effects on bone metabolism, as indicated by emerging reports of osteopenia, osteoporosis, and avascular necrosis.Keywords
This publication has 44 references indexed in Scilit:
- Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapyAIDS, 2001
- Lactic Acidosis and Hepatic Steatosis Associated with Use of Stavudine: Report of Four CasesAnnals of Internal Medicine, 2000
- Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicityClinical Therapeutics, 2000
- Steatosis–lactic acidosis syndrome associated with stavudine and lamivudine therapyAIDS, 2000
- Sodium Bicarbonate for the Treatment of Lactic AcidosisChest, 2000
- Lactic Acidosis Associated with Stavudine Administration: A Report of Five CasesClinical Infectious Diseases, 2000
- Adverse effects of reverse transcriptase inhibitorsAIDS, 1998
- Riboflavin to treat nucleoside analogue-induced lactic acidosisThe Lancet, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndromeCritical Care Medicine, 1997